is tirzepatide on the fda shortage list Compounders protest as removes off GLP-1 Saga Continues: FDA Ends

Poor GLP-1 injection technique and inadequate site rotation are the primary risk factors

One such side effect gaining attention is hair loss, prompting many to wonder about the connection between GLP-1 medications and hair health

The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle

From this model, it is estimated that as a result of the competition with icodec for albumin binding locally at the injection site, less than 1% of semaglutide is bound to albumin in the subcutis following IcoSema administration (Alifrangis L., 2025, unpublished data)